Category Specific RSS

biotech

Aussie cancer researcher primed for 2023 with groundbreaking clinical trial data releases scheduled

Aussies are some of the most enthusiastic adopters of new clinical drugs. In 2019, 95,000 of us participated in nearly…

4 years ago

Pharmaxis cancer drug progress detailed at leading scientific conference, eyes FDA discussions in 2023

Having delivered impressive interim trial data from their Phase 2 clinical trials for a treatment targeting incurable bone marrow cancer,…

4 years ago

Platinum Asset Management identify value opportunity in Pharmaxis with $1.9m stake

When it comes to biotech investing, the value opportunities in Australia attract many of the world's smartest investors. Amongst them,…

4 years ago

The age of mRNA therapeutics is now – with exosomes

mRNA therapeutics are now expected to become the third major class of drugs. But converting their promise into reality, just…

4 years ago

Cynata teams up with Leiden University Medical Center to test its stem cell solution on kidney transplant patients

For the past few years, stem cells have come out on top as a reliable solution to many health concerns,…

4 years ago

Not getting enough shut eye? Medibio opens new trial looking at sleep disturbances and mental health factors

(Not so) fun fact for your Thursday morning: sleep deprivation was (and I’m sure, still is) used as a form…

4 years ago